← Leaderboards
Jin-Hong Chang
Massachusetts Eye And Ear Infirmary
$1,951,450
Attributed
$1,951,450
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $264.9K · FY2005–24$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,951,450 · 3
VA$0 · 2
By mechanism
R01$1,078,875 · 1
R21$872,575 · 2
I01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at Massachusetts Eye And Ear Infirmary
Same institution · by research overlap
- Pedram Hamrah$15,767,152
Others in their field
Top investigators on “Angiogenesis”
- David Heimbrook · Leidos Biomedical Research, Inc.$75,067,502
- Steven Terry Rosen · Beckman Research Institute/City Of Hope$59,567,306
- Martin Friedlander · Scripps Research Institute$48,350,175
- Larry Arthur$33,866,306
- Michael Simons · Yale University$30,647,106
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$29,372,588
Research focus
AngiogenesisCorneaBlindnessInfectionReceptorResponseCorneal InjuryCellsLymphangiogenesisMolecularLymphatic VesselVascular Endothelial Growth FactorsTransplantationVascular Endothelial Growth Factor Receptor-1PreventCorneal NeovascularizationLymphatic Endothelial CellsCorneal EpitheliumKnockout MiceMembraneBlood VesselsAffectKnock-OutVascularization
Grant awards (19)
Modulation of VEGF receptors to prevent limbal stem cell transplant rejection$0
I01 · FY2024 · VA · contact PI
Modulation of VEGF receptors to prevent limbal stem cell transplant rejection$0
I01 · FY2023 · VA · contact PI
Modulation of VEGF receptors to prevent limbal stem cell transplant rejection$0
I01 · FY2022 · VA · contact PI
Modulation of VEGF receptors to prevent limbal stem cell transplant rejection$0
I01 · FY2021 · VA · contact PI
Modulation of VEGF receptors to prevent limbal stem cell transplant rejection$0
I01 · FY2020 · VA · contact PI
Modulation of VEGF receptors to prevent limbal stem cell transplant rejection$0
I01 · FY2019 · VA · contact PI
Endostatin-derived Short Peptides in Corneal Transplantation$0
I01 · FY2017 · VA · contact PI
Endostatin-derived Short Peptides in Corneal Transplantation$0
I01 · FY2016 · VA · contact PI
Endostatin-derived Short Peptides in Corneal Transplantation$0
I01 · FY2015 · VA · contact PI
VEGFR2 Modulates Corneal Angiogenesis and Lymphangiogenesis$195,387
R21 · FY2014 · EY · contact PI
Endostatin-derived Short Peptides in Corneal Transplantation$0
I01 · FY2014 · VA · contact PI
VEGFR2 Modulates Corneal Angiogenesis and Lymphangiogenesis$239,250
R21 · FY2013 · EY · contact PI
Inhibition of VEGF receptor dimerization and signaling in corneal lymphangiogenes$199,375
R21 · FY2012 · EY · contact PI
Inhibition of VEGF receptor dimerization and signaling in corneal lymphangiogenes$238,563
R21 · FY2011 · EY · contact PI
Collagen XVIII in Corneal Neovascularization$264,875
R01 · FY2006 · EY · contact PI
Collagen XVIII in Corneal Neovascularization$148,610
R01 · FY2005 · EY
Collagen XVIII in Corneal Neovascularization$110,390
R01 · FY2005 · EY
Collagen XVIII in Corneal Neovascularization$296,000
R01 · FY2004 · EY
Collagen XVIII in Corneal Neovascularization$259,000
R01 · FY2003 · EY